Malignant Hypertension Without End-Organ Damage Secondary to Stressful Condition in a Female

被引:1
作者
Hussain, Hussain [1 ]
Fadel, Aya [2 ]
机构
[1] Cardiol Clin, Internal Med, Pasadena, CA 91105 USA
[2] Florida Int Univ, Hialeah Hosp, Internal Med, Miami, FL 33199 USA
关键词
malignant hypertension; hypertensive emergency; physiological changes in stress; hypertension; catecholamines;
D O I
10.7759/cureus.10109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant hypertension (hypertensive emergency), is an extreme elevation of blood pressure under certain conditions that can lead to organ damage and other serious consequences. It is a common condition that affects about one in three Americans, according to the Centers for Disease Control and Prevention. An elevation of systolic blood pressure above 180 mmHg and diastolic blood pressure above 120 mmHg is considered a hypertensive emergency. This article addresses the case of a 61-year-old female patient who presented to the ER with a semicomatose and gasping condition and response to painful stimuli with an unclear voice. She also had unstable vital signs, with a blood pressure of 370/200 mmHg, a pulse rate of 115, a respiratory rate of 22, and a pulse oximetry of 96%, but no fever. Her son provided a brief history and reported that a stressful condition had occurred at home one hour before; she had begun to scream and been brought to the ER by ambulance in the condition described above. Cardiac monitoring and an electrocardiograph were performed and indicated a normal condition besides the unstable vital signs. Oxygen was administered via a nasal cannula with 20 mg of intravenous hydralazine, and the patient's blood pressure improved progressively. Moreover, she regained consciousness with no end-organ damage. A hypertensive emergency is usually associated with end-organ damage, such as heart, kidney, eye, or brain damage. However, in this case, despite the extreme elevation of her blood pressure, the patient suffered no organ damage. It is essential to manage the extreme elevation of blood pressure as soon as possible and monitor the patient for consequences.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Trends in Hospitalization for Hypertensive Emergency, and Relationship of End-Organ Damage With In-Hospital Mortality
    Shah, Mahek
    Patil, Shantanu
    Patel, Brijesh
    Arora, Shilpkumar
    Patel, Nilay
    Garg, Lohit
    Agrawal, Sahil
    Jacobs, Larry
    Steigerwalt, Susan P.
    Martinez, Matthew W.
    AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (07) : 700 - 706
  • [22] The combination of atenolol and amlodipine is better than their monotherapy for preventing end-organ damage in different types of hypertension in rats
    Han, Ping
    Shen, Fu-Ming
    Xie, He-Hui
    Chen, Yuan-Yuan
    Miao, Chao-Yu
    Mehta, Jawahar L.
    Sassard, Jean
    Su, Ding-Feng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (04) : 726 - 734
  • [23] Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension
    Maitland, Karlene
    Bridges, LaKeesha
    Davis, Wendell P.
    Loscalzo, Joseph
    Pointer, Mildred A.
    CIRCULATION, 2006, 114 (09) : 905 - 911
  • [24] Left atrial volume changes are an early marker of end-organ damage in essential hypertension: A multidisciplinary approach to an old problem
    Kanar, Batur
    Ozben, Beste
    Kanar, Hatice Selen
    Arsan, Aysu
    Tigen, Kursat
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2017, 34 (12): : 1895 - 1902
  • [25] Male gender and not the severity of hypertension is associated with end-organ damage in aged stroke-prone spontaneously hypertensive rats
    Masineni, SN
    Chander, PN
    Singh, GD
    Powers, CA
    Stier, CT
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (06) : 878 - 884
  • [26] Cardiac end-organ changes: Comparison between white coat hypertension and persistent mild hypertension
    Lue, BH
    Hsu, KL
    Tseng, YZ
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1996, 95 (06) : 440 - 445
  • [27] DETERMINING HYPERTENSIVE END-ORGAN DAMAGE IN TRIALS - A REVIEW OF CURRENT METHODOLOGIES AND TECHNIQUES
    BIRKENHAGER, WH
    DELEEUW, PW
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S43 - S50
  • [28] Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage
    Altara, Raffaele
    da Silva, Gustavo J. J.
    Frisk, Michael
    Spelta, Francesco
    Zouein, Fouad A.
    Louch, William E.
    Booz, George W.
    Cataliotti, Alessandro
    HYPERTENSION, 2020, 75 (05) : 1195 - 1204
  • [29] Double product and end-organ damage in African and Caucasian men: The SABPA study
    Schultz, A. J.
    Schutte, A. E.
    Schutte, R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (03) : 792 - 797
  • [30] Cytosolic Phospholipase A2α Is Essential for Renal Dysfunction and End-Organ Damage Associated With Angiotensin II-Induced Hypertension
    Khan, Nayaab S.
    Song, Chi Young
    Thirunavukkarasu, Shyamala
    Fang, Xiao R.
    Bonventre, Joseph V.
    Malik, Kafait U.
    AMERICAN JOURNAL OF HYPERTENSION, 2016, 29 (02) : 258 - 265